Skip to main content

Table 1 Examples of AD treating agents, their mechanism of treatment, and their current status

From: Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach

Hypothesis

Treating agents

Mechanism of available treatments

Current status

Remarks

References

Amyloid cascade hypothesis

Plasma exchange with albumin 1 immunoglobulin

Exchange of plasma to remove the amyloid

Phase-III clinical trial

Ongoing research

[8, 9]

ALZT-OP1a + ALZT-OP1b

Alleviation of amyloid plaque related neuroinflammation

Phase-III clinical trial

Ongoing research

Elenbecestat

Removal of amyloid by inhibiting Beta-secretase 1

Phase-III clinical trial

Ongoing research

Solanezumab

Monoclonal antibodies targeting amyloid plaque

Failed

Lack of efficacy

Verubecestat

Removal of amyloid by inhibiting Beta-secretase 1

Failed

Lack of efficacy

Lanabecestat

Removal of amyloid by inhibiting Beta-secretase 1

Failed

Lack of efficacy

CAD106

Vaccine-based therapy

Phase-II clinical trial

Ongoing research

CNP520

Inhibition of Beta-secretase 1

Phase-II clinical trial

Ongoing research

Crenezumab

Monoclonal antibody targeting amyloid plaque

Ongoing investigation

Ongoing research

Neflamapimod

Inhibition of inflammatory protein p38α MAPK

Ongoing investigation

Ongoing research

Aducanumab

Monoclonal antibody targeting amyloid plaque

Phase-III clinical trial

Ongoing research

Oxidative stress hypothesis

Supplementation of Vitamin C and Vitamin E

Antioxidant to neutralize the ROS

Current investigational treatment

Ongoing study

[10, 11]

Selenium

Antioxidant to neutralize the ROS

Ongoing investigation

Ongoing study

Curcumin

Antioxidant to neutralize the ROS

Current investigational treatment

Ongoing study

Ginko biloba

Antioxidant to neutralize the ROS

Current treatment

Most effective among the available treatments

Ebenone

Antioxidant to neutralize the ROS

Ongoing investigation

Ongoing study

Estrogen

Antioxidant to neutralize the ROS

Ongoing investigation

Ongoing study

Colostrinin

Antioxidant to neutralize the ROS

Ongoing investigation

Ongoing study

Cholinergic hypothesis

Tacrine

Inhibition of acetylcholinesterase

Current treatment

Approved by FDA

[12]

Donepezil

Inhibition of acetylcholinesterase

Current treatment

Approved by FDA

Galantamine

Inhibition of acetylcholinesterase

Current treatment

Approved by FDA

Rivastigmine

Inhibition of acetylcholinesterase

Current treatment

Approved by FDA

  1. ROS reactive oxygen species, FDA Food and Drug Administration